Nuance Communications, Inc. (NASDAQ: NUAN), today announced that customers using Nuance Clintegrity 360™ | Coding report high customer confidence and satisfaction levels in Nuance’s quality and timeliness of implementations, customer support, and ICD-10 readiness according to customer feedback provided to KLAS Enterprises. A lack of timely vendor upgrades and coding resources are among the top external threats providers face to a successful ICD-10 implementation, according to a recent study by the American Hospital Association. Many vendors are lagging behind in developing and releasing ICD-10-ready products or lack the resources to help healthcare providers adhere to the necessary changes and test them in time. Nuance is the leader in on-time implementations, and quality of training and implementation for coding solutions – factors increasingly important to U.S. healthcare providers as they prepare for ICD-10. Organizations big and small face a profound financial impact if employees are not properly prepared to ensure accuracy of clinical documentation and coding of patient care under ICD-10. Clintegrity 360 | Coding was the first encoder on the market capable of dual coding in ICD-9 and ICD-10 and customers are expressing confidence in their readiness for the transition. According to KLAS findings, customers show a high level of satisfaction in product performance and trust in Nuance in helping them achieve HIPAA and ICD-10 compliance. “…We are very happy with our relationship with Nuance and with how the product works. It saves us a lot of time and money. We looked at other vendors, like 3M and OptumInsight, but their costs were higher and we didn’t hear glowing reviews about them. We felt like Nuance had the best solution for our needs.”- VP/Other Executive. “Clintegrity (Quantim) Coding is a workhorse. We have had it for many years and it continues to perform very well. I do not worry about HIPAA and ICD-10 because Nuance is always on top of things. They have proven this to us time and time again.” – Director.